GeoVax Labs, Inc. - Equity Warrant

Introduction

This page provides a comprehensive analysis of the known insider trading history of Mark Reynolds. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Mark Reynolds has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:GOVX / GeoVax Labs, Inc. CFO 14,013
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mark Reynolds. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases GOVXW / GeoVax Labs, Inc. - Equity Warrant - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in GOVXW / GeoVax Labs, Inc. - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2025-03-31 GOVX Reynolds Mark 6,800 1.0799 6,800 1.0799 7,343 77 1.3200 1,633 22.24
2024-02-07 GOVX Reynolds Mark 2,000 2.7700 2,000 2.7700 5,540
2023-08-18 GOVX Reynolds Mark 10,000 0.5179 667 7.7685 5,179
2023-04-20 GOVX Reynolds Mark 8,000 0.6300 533 9.4500 5,040
2020-09-29 GOVX Reynolds Mark 60,184 5.0000 4,012 75.0000 300,920
2015-04-23 GOVX Reynolds Mark 10,000 0.1780 16 112.8075 1,780
2015-04-22 GOVX Reynolds Mark 10,000 0.1700 16 107.7375 1,700
2015-04-22 GOVX Reynolds Mark 10,000 0.1735 16 109.9556 1,735
2012-01-31 GOVX Reynolds Mark 15,000 0.6700 24 424.6125 10,050
2011-12-30 GOVX Reynolds Mark 15,000 0.6700 24 424.6125 10,050

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GOVXW / GeoVax Labs, Inc. - Equity Warrant Insider Trades
Insider Sales GOVXW / GeoVax Labs, Inc. - Equity Warrant - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in GOVXW / GeoVax Labs, Inc. - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GOVXW / GeoVax Labs, Inc. - Equity Warrant Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Mark Reynolds as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2025-03-31 2025-03-31 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 6,800 14,013 94.27 1.08 7,343 15,133
2024-02-07 2024-02-07 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 2,000 7,213 38.37 2.77 5,540 19,980
2023-08-21 2023-08-18 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 10,000 78,184 14.67 0.52 5,179 40,491
2023-04-21 2023-04-20 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 8,000 68,184 13.29 0.63 5,040 42,956
2021-12-08 2021-12-07 4 GOVX GeoVax Labs, Inc.
Stock Option (right to buy) 		A - Award 48,200 48,200
2021-08-11 2021-08-11 4 GOVX GeoVax Labs, Inc.
Stock Option (right to buy) 		A - Award 128,000 128,000
2020-09-29 2020-09-29 4 GOVX GeoVax Labs, Inc.
Common Stock Purchase Warrant 		P - Purchase 60,184 60,184
2020-09-29 2020-09-29 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 60,184 60,184 5.00 300,920 300,920
2018-12-19 2018-12-17 4 GOVX GeoVax Labs, Inc.
Common Stock Purchase Option 		A - Award 750,000 750,000
2017-12-22 2017-12-20 4 GOVX GeoVax Labs, Inc.
Common Stock Purchase Option 		A - Award 750,000 750,000
2016-12-15 2016-12-13 4 GOVX GeoVax Labs, Inc.
Common Stock Purchase Option 		A - Award 335,000 335,000
2015-12-14 2015-12-11 4 GOVX GeoVax Labs, Inc.
Stock Purchase Option 		A - Award 60,000 60,000
2015-04-23 2015-04-23 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 10,000 66,000 17.86 0.18 1,780 11,748
2015-04-23 2015-04-22 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 10,000 56,000 21.74 0.17 1,735 9,716
2015-04-23 2015-04-22 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 10,000 46,000 27.78 0.17 1,700 7,820
2014-12-11 2014-12-09 4 GOVX GeoVax Labs, Inc.
Stock Option 		A - Award 30,000 30,000
2013-12-20 2013-12-18 4 GOVX GeoVax Labs, Inc.
Stock Option 		A - Award 30,000 30,000
2013-01-03 2012-12-11 4 GOVX GeoVax Labs, Inc.
Stock Option 		A - Award 25,000 25,000
2012-02-01 2012-01-31 4 GOVX GeoVax Labs, Inc.
Stock Purchase Warrant 		P - Purchase 22,500 22,500
2012-02-01 2012-01-31 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 15,000 36,000 71.43 0.67 10,050 24,120
2012-01-04 2011-12-30 4 GOVX GeoVax Labs, Inc.
Stock Option 		A - Award 25,000 25,000
2012-01-04 2011-12-30 4 GOVX GeoVax Labs, Inc.
Stock Purchase Warrant 		P - Purchase 22,500 22,500
2012-01-04 2011-12-30 4 GOVX GeoVax Labs, Inc.
Common Stock 		P - Purchase 15,000 21,000 250.00 0.67 10,050 14,070
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)